Penetrating Aortic Ulcer
9
4
7
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (9)
Zenith Thoracic Alpha (ZTA) Post-Market Data Collection
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases
Thoraflex Hybrid Post-Market Study
CRATOS - Evaluation of Cratos™ Branch Stent Graft System in Treatment of Descending Aorta Lesions
Quick Yielding Modified Short-Distance Fenestration Technique for the Treatment of Complex Aortic Arch Diseases: a Multicenter Single-Arm Objective Performance Criteria Trial(QYM-Tech Study)
18F Sodium Fluoride PET/CT in Acute Aortic Syndrome
Modified Preloaded System for Renal Arteries in Fenestrated Endografting (MPSRA)